General MedicationsTOPICALGeneric

BACTROBAN

MUPIROCIN CALCIUM

Standard Dose

EQ 2% BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Max Dose

Refer to approved labeling

Primary Use

Review priority: STANDARD Marketing status: Discontinued

Summary

Approval overview BACTROBAN is listed in Drugs@FDA under application 050746 (NDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient MUPIROCIN CALCIUM Form and strength CREAM;TOPICAL - EQ 2% BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor GLAXOSMITHKLINE Submission history Latest submission status date: 2020-02-19 00:00:00.

Structured Monograph

Clinical summary

Approval overview BACTROBAN is listed in Drugs@FDA under application 050746 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient MUPIROCIN CALCIUM Form and strength CREAM;TOPICAL - EQ 2% BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor GLAXOSMITHKLINE Submission history Latest submission status date: 2020-02-19 00:00:00. Submission type: SUPPL.

Monitoring

• Marketing status: Discontinued
• Review priority: STANDARD

Interaction Notes

No interaction notes stored yet.